Dr. Wang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1735 SW Health Pkwy
Ste 201
Naples, FL 34109Phone+1 239-249-7800Fax+1 239-249-7803
Education & Training
Montgomery HospitalResidency, Family Medicine, 2001 - 2004
Lewis Katz School of Medicine at Temple UniversityClass of 2001
Certifications & Licensure
FL State Medical License 2006 - 2025
PA State Medical License 2001 - 2010
NC State Medical License 2004 - 2007- American Board of Family Medicine Family Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification athenaClinicals EHR, athenahealth, Inc, 2013
Publications & Presentations
PubMed
- 149 citationsTargeting the insulin-like growth factor-1 receptor to overcome bortezomib resistance in preclinical models of multiple myelomaDeborah J. Kuhn, Zuzana Berkova, Richard J. Jones, Richard Woessner, Chad C. Bjorklund
Blood. 2012-10-18 - 14 citationsA Phase III study of zanubrutinib plus rituximab versus bendamustine plus rituximab in transplant-ineligible, untreated mantle cell lymphoma.Martin Dreyling, Constantine S. Tam, Michael Wang, Stephen D. Smith, Marco Ladetto
Future Oncology. 2021-01-01 - 113 citationsIbrutinib for the treatment of relapsed/refractory mantle cell lymphoma: extended 3.5-year follow up from a pooled analysis.Simon Rule, Martin Dreyling, Andre Goy, Georg Hess, Rebecca Auer
Haematologica. 2019-05-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
